DG Capital Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

DG Capital Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,870	Closed	-$1.83K	–	41
2023 Q1	$1.83K	Hold	25,870	–	–	﹤0.01%	27
2022 Q4	$4.23K	Buy	25,870 +337	+1%	+$39	﹤0.01%	26
2022 Q3	$3K	Hold	25,533	–	–	﹤0.01%	31
2022 Q2	$4K	Hold	25,533	–	–	﹤0.01%	52
2022 Q1	$9K	Sell	25,533 -9,467	-27%	-$4.88K	﹤0.01%	120
2021 Q4	$34K	Hold	35,000	–	–	0.01%	113
2021 Q3	$32K	Buy	+35,000	New	+$45.5K	0.01%	149

DG Capital Management's ORIAW Position: Q2 2023 in Review

DG Capital Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 25,870 shares — an estimated $1.83K sold.

DG Capital Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $34K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

DG Capital Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
DG Capital Management sold 25,870 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $1.83K.
DG Capital Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
DG Capital Management's Orion Biotech Opportunities Corp. Warrant position peaked at $34K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on DG Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.